What's it really like to live with eczema?
Have you ever wished you could tell the people who research, develop & regulate treatments for eczema what's most important to you?
Now is your chance!
For the first time, people living with eczema and those who care for and about them are invited to share their experiences with the people who research, develop, and regulate treatments for eczema.
On September 23, 2019 the first patient-focused drug development (PFDD) meeting dedicated to eczema will be held September 23, 2019 near Washington, D.C.
Five organizations serving the eczema community have joined together to make sure FDA staff, drug and medical device developers, and other stakeholders hear directly from people living with eczema about the many burdens of the condition and the treatment outcomes that matter most to them.
On September 23, 2019 the first patient-focused drug development (PFDD) meeting dedicated to eczema will be held September 23, 2019 near Washington, D.C.
Five organizations serving the eczema community have joined together to make sure FDA staff, drug and medical device developers, and other stakeholders hear directly from people living with eczema about the many burdens of the condition and the treatment outcomes that matter most to them.
